Basic Science
Breastfeeding/Human Milk
Infectious Diseases
Neonatology
Pediatric Nutrition
Sagori Mukhopadhyay, MD, MMSc (she/her/hers)
Associate Professor
Childrens Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
David Kaufman, MD
Neonatologist
University of Virginia, United States
The neonatal microbiome can be both a protector from and a source of pathogens resulting in sepsis. A better understanding of the neonatal microbiome can inform interventions to interrupt disease transmission, delineate risk for infection, and improve outcomes in infants with infection. Microbiome-based interventions to reduce sepsis seek to either strengthen its protective role by supporting a diverse ecosystem or reduce its potential as a reservoir for opportunistic pathogens. However, these strategies can counteract each other unless carefully tailored to the context. Currently, the risk-benefit of interventions modifying the microbiome to improve infection risk remains an area of active research. In this session we discuss the evolving understanding of the role of the microbiome that can inform clinical choices and identify direction for future research.
Speaker: Carolyn M. McGann, MD (she/her/hers) – Childrens Hospital of Philadelphia
Speaker: Drew Joel Schwartz, MD, PhD (he/him/his) – Washington University School of Medicine
Speaker: Barbara Warner, MD, MSci (she/her/hers) – Washington University in St. Louis School of Medicine
Speaker: Richard A. Polin, MD – Columbia University Vagelos College of Physicians and Surgeons
Speaker: David Kaufman, MD – University of Virginia